Pharmaceutical plastic bottles are used in the packaging of pharmaceutical products, including pills and supplements. These bottles come in a variety of colors and have varying capacities. Some models also have light-resistant properties, which is beneficial for products that are highly sensitive to light. FDA-approved bottles are also available for products that must follow stringent guidelines.
Market Dynamics:
Growing need for lightweight pharma bottles by consumers is a prime factor propelling growth of the pharmaceutical plastic bottles market. Moreover, increasing spending on healthcare and pharmaceutical sector is again fostering market growth. For instance, according to IQVIA, a human data science company, pharmaceutical sales worldwide are anticipated to reach USD 1.5 trillion in 2023 from USD 491 billion in 2019. The United States dominates the pharmaceutical market, both in consumption and development. According to the STAT, prescription drug spending in the nation is considered to add up to USD 600 billion by 2023, up from an estimated USD 500 billion in 2019. Major demand would come from diabetics and chronic disease patients.
On the other hand, increasing price of raw materials is expected to restrict the market growth.
Key features of the study:
- This report provides in-depth analysis of the global pharmaceutical plastic bottles market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global pharmaceutical plastic bottles market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Amcor Limited, Gerresheimer AG, Berry Group Inc., Aptar Pharma, O.Berk Company LLC, Alpha Packaging, Pro-Pac Packaging Ltd, COMAR LLC, Gil Plastic Products Ltd, Drug Plastics Group, and Frapak Packaging
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global pharmaceutical plastic bottles market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmaceutical plastic bottles market
Detailed Segmentation:
- Global Pharmaceutical Plastic Bottles Market, By Raw Material:
-
- Polyethylene Terephthalate (PET)
- Poly Propylene (PP)
- Low Density Polyethylene (LDPE)
- High Density Polyethylene (HDPE)
- Global Pharmaceutical Plastic Bottles Market, By Type:
-
- Solid Containers
- Dropper Bottles
- Nasal Spray Bottles
- Liquid Bottles
- Oral Care
- Other Types
- Global Pharmaceutical Plastic Bottles Market, By Geography:
-
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
- Company Profiles:
-
- Amcor Limited
- Gerresheimer AG
- Berry Group Inc.
- Aptar Pharma
- Berk Company LLC
- Alpha Packaging
- Pro-Pac Packaging Ltd
- COMAR LLC
- Gil Plastic Products Ltd
- Drug Plastics Group
- Frapak Packaging
